GRÜNENTHAL ANNOUNCES ACQUISITION OF THE RIGHTS TO CIALIS® FROM LILLY IN MEXICO, BRAZIL & COLOMBIA

Contributed by: News Aktuell

Issued by news aktuell/OTS on behalf of Grünenthal Group

Logo

Tags

Business enterprise

Health

More Like This

GRÜNENTHAL TAKES FULL OWNERSHIP OF GRÜNENTHAL MEDS, THE JOINT VENTURE ESTABLISHED WITH KYOWA KIRIN FOR ITS ESTABLISHED MEDICINES BRANDS

GRÜNENTHAL LICENSES EXCLUSIVE CANADIAN RIGHTS TO TESTOSTERONE REPLACEMENT THERAPY NEBIDO® TO APOTEX

Valinor Pharma Announces Acquisition by Grünenthal with a Total Deal Value of Approximately $250 Million

MAREN THUROW STARTS AS NEW HEAD GLOBAL COMMUNICATIONS AT GRÜNENTHAL

PR Newswire associated0

Cosmo and Glenmark announce the signing of Distribution and License Agreements for Winlevi® in Europe and South Africa

PR Newswire associated0

GTCR Completes Acquisition of Zentiva, a Leading European Generics Pharmaceutical Company

APOTEX LICENSES EXCLUSIVE CANADIAN RIGHTS TO QUTENZA® FROM GRÜNENTHAL

GRÜNENTHAL LICENSES EXCLUSIVE AUSTRALIAN RIGHTS TO QUTENZA® TO CLINECT